4. Hexose monophosphate pathway
• Also called pentose phosphate pathway ‘PPP’.
• About 5% of glycolysis occurs by this pathway.
• In which:
5. Introduction
• FUNCTION OF G6PD
• Regenerates NADPH, allowing regeneration of
glutathione
• Protects against oxidative stress
• Lack of G6PD leads to hemolysis during
oxidative stress- infection, medication, fava
beans
• Oxidative stress leads to Heinz body
formation, extravascular hemolysis
6. • Pentose pathway also called the
phosphogluconate pathway and the hexose
monophosphate shunt is a process that
generates NADPH and pentoses (5-carbon
sugar)
OHHHWW MAAI GAAD!!!!
PENTOSE PATHWAY?????
(Oxidised form)(Reduced form)
7. History & Definition
• It was discovered in 1950s after it was
observed that some black soldiers
receiving antimalarial drug primaquine
developed hemolytic anemia.
• It is the most common red cell
enzymopathy associated with hemolysis.
• Large no. of abnormal genes code for the
8. Definition
• X-linked disease , sesult in G6PD
Deficiency (RBCs enzym deficiency )
asymptomatic unless Oxidative stress
causes the RBC’s to break apart.
• Inherited –, Recessive
9. Genetics
• The G6PD gene is located on the X
chromosome
• Thus the deficiency state is a sex-linked trait
• Affected males inherit the abnormal gene
from their mothers who are usually carriers
(heterozygotes)
12. G6PD variants
• There are over 400 variants of the G6PD enzyme:
• G6PD A and G6PD B are the well known variants.
G6PD B: The normal G6PD enzyme.
G6PD A: found with normal enzyme activity but
differ from B by a single amino acid substitution,
resulting in a different in electrophoretic
mobility.
13. G6PD variants
G6PD A : the common one associated with
haemolysis, electrophoretically identical to A
but has only 5- 15% of the normal enzymatic
activity.
Mediterranean G6PD: electrophoretically
identical to B but its activity is often 1% less
than normal.
14. World Health Organization classifies
for G6PD genetic variants
• Class I: Severe deficiency (<10% activity) with
chronic (nonspherocytic) hemolytic anemia
• Class II: Severe deficiency (<10% activity),
with intermittent hemolysis
• Class III: Mild deficiency (10-60% activity),
hemolysis with stressors only
15. • Class IV: Non-deficient variant, no
clinical sequelae
• Class V: Increased enzyme activity, no
clinical sequelae
World Health Organization classifies
for G6PD genetic variants
16. • Individuals who have inherited one of the many G6PD mutations do not show
clinical manifestation.
• Some of patients with G6PD develop hemolytic anemia if they are exposed or
ingest any of the followings oxidizing agents:
1-1-Oxidant drugsOxidant drugs: Remember “AAA”?
AntibioticsAntibiotics : e.g. sulfamethoxazole
AntimalariasAntimalarias : e.g. primaquine
AntipyreticsAntipyretics : e.g. acetanilid
2-2- Favism:Favism:
The hemolytic effect of ingesting of fava beans is not observed in all
individuals with G6PD deficiency but all patients with favism have G6PD
deficiency
factors cause G6PD deficiency:factors cause G6PD deficiency:
17. G6PD Deficiency
• Biochemistry – summary
• G6PD
Reduces
• NADP+
• to
• NADPH
Which is
responsible for
• Glutathione
Which fights
• Free radicals
Which damage
blood cells
18. Pathophysiology
• Oxidative denaturation of hemoglobin is the
major cause of H. A in G6PD deficiency
• It is important in the conversion of glucose-6-
P to phosphogluconate
• For subsequent production of NADPH &
reduced glutathione (GSH)
• GSH protects enzymes & hemoglobin against
oxidation by reducing H2O2 & free radicals
19. Pathophysiology
• H2O2 is generated normally in small amounts
during normal red cell metabolism
• Larger amounts produced when an oxidant
drug interacts with oxyhemoglobin
• Normal red cells have sufficient G6PD
activity to maintain adequate GSH levels
• When deficient, red cells fail to produces
sufficient G6PD to detoxify peroxide
20. Pathophysiology
• Hb is then oxidized to Hi, heme is
liberated from globin & globin denatures
producing Heinz bodies
• Heinz bodies attach to membrane
sulfhydryl groups inducing cell rigidity
• At this point red cells can no longer
traverse the splenic microcirculation
• Hence lysis occurs
21. Symptoms
• Persons with this condition do not display any signs of
the disease until their red blood cells are exposed to
certain chemicals in food or medicine, or to stress.
• Symptoms are more common in men and may include:
• Dark urine
• Enlarged spleen
• Fatigue
• Pallor
• Rapid heart rate
• Shortness of breath
• Yellow skin color (jaundice)
22. G6PD Deficiency
• Malaria Treatment
– chloroquine
– atovaquone-proguanil (Malarone®)
– artemether-lumefantrine (Coartem®)
– mefloquine (Lariam®)
– quinine
– quinidine
– doxycycline (used in combination with quinine)
– clindamycin (used in combination with quinine)
– primaquine
23. Diagnosis ofDiagnosis of
G6PD Deficiency Hemolytic AnemiaG6PD Deficiency Hemolytic Anemia
1-CBC
Bite cells, blister cells, irregular small
cells, Heinz bodies, polychromasia
G-6-PD level
Bite” cells
Spleen removes portion of RBC that had Heinz
body, preventing intravascular hemolysis
• 2-Screening:
• Qualitative assessment of G6PD enzymatic activity
(UV-based test)
24. Diagnosis ofDiagnosis of
G6PD Deficiency Hemolytic AnemiaG6PD Deficiency Hemolytic Anemia
• 3-Confirmatory test:
• Quantitative measurement of G6PD
enzymatic activity
4-Molecular test:
• Detection of G6PD gene mutation
28. Methemoglobin Reduction Test
• Sodium nitrite converts Hb (hemoglobin)
to Hi (methemoglobin)
• Adding methylene blue should stimulate
the pentose phosphate pathway,
reducing methemoglobin
• In G6PD Deficiency, methemoglobin
persists
29. Methemoglobin Reduction Test
• Normal blood → clear red color
• Deficient blood → brown color
• Deficient blood
Normal blood
30. Clinical Manifestations
• The patient may experience an acute
hemolytic crisis within hours of exposure to
the oxidant stress
• Hemolytic crisis is self-limited even if the
exposure continues &
• Only older cell population is rapidly destroyed
• A minority of patients are sensitive to
exposure to fava beans (favism phenomenon)
31. What is PNH?
• Paroxysmal –
sudden onset
• Nocturnal –
occuring at night
(or early in morning
upon awakeneing)
• Hemoglobinuria
Despite the name, most patients do not present this way.
32. What is PNH?
• A rare and unusual acquired hematologic disorder
characterized by
– Intravascular hemolysis
– Bone marrow failure (cytopenias)
– Thrombosis.
33. What is PNH?
• Intravascular RBCs break down result
from Complement activation due to
absence of CD55, CD59
SymptomsSymptoms
- passage of dark brown urine in the- passage of dark brown urine in the
morningmorning..
34. . PNH –laboratory features:. PNH –laboratory features:
- pancytopenia- pancytopenia
- chronic urinary iron loss- chronic urinary iron loss
- serum iron concentration decreased- serum iron concentration decreased
- hemoglobinuria- hemoglobinuria
- hemosiderinuria- hemosiderinuria
-- positive Ham’s test (acid hemolysis test)positive Ham’s test (acid hemolysis test)
- positive sugar-water test- positive sugar-water test
- specific immunophenotype of erytrocytes- specific immunophenotype of erytrocytes
(CD59, CD55)(CD59, CD55)
Hinweis der Redaktion
So, an effected father will transmit the disease to all of his daughters and none of his sons. Whereas, a carrier mother will transmit the disease to half of her children. Half of her daughter will be carriers and half of her sons will be directly affected with the condition.
G6PD, under normal conditions, is responsible for the maintenance of Nicotinamide adenine dinucleotide phosphate (NADP+) and its conversation to NADPH. NADPH is responsible for regenerating glutathione and the removal of free radicals which cause damage to blood cells.
Free radicals are molecules that are missing an electron. Generally, free radicals attack the nearest stable molecule, &quot;stealing&quot; its electron. When the &quot;attacked&quot; molecule loses its electron, it becomes a free radical itself, beginning a chain reaction. Once the process is started, it can cascade, finally resulting in the disruption of a living cell.
Glutathione eliminates the free radical by donating the needed electron and converting the free radical into a more stable byproduct such as water (H2O).
These are some of the drugs that are typically used for malaria treatment. However, they are either contraindicated in G6PD patients, high risk, possibly dose restricted, not indicated for prophylactic treatment. The biggest problem is the rapid spread of drug resistant malarial strains.